A Study to Investigate the Efficacy and Tolerability of ESO-101 in Patients With Eosinophilic Esophagitis

Clinical trial NCT04849390 · COMPLETED

Trial details

NCT number: NCT04849390
Sponsor: EsoCap AG
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Eosinophilic Esophagitis

Start date: 2021-06-29
Primary completion: 2023-10-09
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.